Table 1.
Baseline patient characteristics
| Variable | N | Proportion |
|---|---|---|
| Median age (years) | 59 (range 31–76) | |
| Male sex | 17 | 43% |
| Race | ||
| White | 30 | 75% |
| Black | 6 | 15% |
| Hispanic | 3 | 8% |
| Asian | 1 | 2% |
| Primary cancer diagnosis | ||
| Prostate | 9 | 23% |
| Lung | 7 | 18% |
| Ovarian | 6 | 15% |
| Breast | 5 | 13% |
| Gastrointestinal/hepatobiliary | 3 | 8% |
| Renal/adrenal | 2 | 5% |
| Lymphoma | 2 | 5% |
| Central nervous system | 1 | 2% |
| Uterine | 1 | 2% |
| Thyroid | 1 | 2% |
| Bladder | 1 | 2% |
| Melanoma | 1 | 2% |
| Sarcoma | 1 | 2% |
| Extent of prior cancer treatment | ||
| Patients with at least one prior course of radiation | 19 | 48% |
| Average number of prior lines of chemotherapy per patient | 2 (range, 0–7) | |
| Prior palliative care | ||
| Patients with prior palliative care consultations | 2 | 5% |
| Reasons for radiation oncology consultation | ||
| Pain | 24 | 60% |
| Neurologic symptoms (e.g, weakness, numbness) | 11 | 28% |
| Bleeding (e.g. vaginal, gastrointestinal) | 4 | 10% |
| Obstruction (e.g. of blood/lymph flow by mass compression) | 1 | 2% |
| Treatment site | ||
| Spine | 15 | 38% |
| Bone | 12 | 30% |
| Soft tissue | 10 | 25% |
| Brain | 3 | 8% |